Status:

COMPLETED

Omentectomy and Metabolic Syndrome

Lead Sponsor:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Conditions:

Metabolic Syndrome

Morbid Obesity

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

The aim of the present study was to evaluate the additional effect of sudden visceral fat reduction by omentectomy on Metabolic Syndrome, acute phase reactants and inflammatory mediators in patients w...

Detailed Description

Although weight loss controls Metabolic Syndrome and reduces the level of inflammatory markers in patients with Morbid Obesity, patients may enjoy the benefit achieving metabolic control before signif...

Eligibility Criteria

Inclusion

  • BMI \> 35 Kg/m2
  • Metabolic syndrome diagnosed

Exclusion

  • Type 1 diabetes
  • Uncontrolled type 2 diabetes
  • Cirrhosis or active hepatitis
  • Pregnancy
  • Recent MI or stroke

Key Trial Info

Start Date :

December 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2008

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00923260

Start Date

December 1 2005

End Date

July 1 2008

Last Update

December 7 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.